Product News: Health, Medical and Dental Supplies & Equipment, Optics & Photonics

Hybrid Fractional Laser minimizes patient downtime.

Share Like Tweet Add Email

Press Release Summary:

March 27, 2014 - Applying tunable non-ablative and ablative wavelengths to same microscopic treatment zone in single pass, Halo uses 1,470 nm wavelength to deliver 100–700 microns of coagulation to epidermis and dermis, where solar damage exists, and 2,940 nm wavelength to deliver 0–100 microns for ablation to epidermis of skin. Operator may choose 1 of 3 coverage-base treatment levels, and Halo calculates exact amount of energy necessary to complete safe and effective treatment.

Sciton, Inc.

925 Commercial St., Palo Alto, CA, 94303, USA

Original Press Release

Sciton Launches Halo at AAD; the World's First Hybrid Fractional Laser (HFL) for Fractional Ablative Results with Non Ablative Downtime

Press release date: March 20, 2014

PALO ALTO, Calif.,  -- Great news for patients wanting the best possible results from their laser treatment with the lowest possible downtime. Sciton(®), a leading manufacturer of high-quality laser and light systems in the aesthetic medical market, announces Halo, the world's first and only hybrid fractional laser, applying tunable non-ablative and ablative wavelengths in a single pass to maximize results and reduce downtime. Sciton will be premiering Halo at the 72(nd) Annual Meeting of the American Academy of Dermatology. "Halo is not an incremental product. It is the culmination of an extensive 4 year investigation involving new understanding of laser tissue physics combined with state-of-the-art implementation of all new technology," said Dan Negus, President of Sciton. "This product has some very exciting innovations that will excite a lot of users. Launching Halo further demonstrates Sciton's long commitment to excellence and innovation across all types of resurfacing."

Halo delivers both ablative and non-ablative wavelengths to the same microscopic treatment zone: 1470 nm for coagulation and 2940 nm for ablation. The 1470 nm wavelength is used for delivering between 100 and 700 microns of coagulation to the epidermis and dermis, where solar damage exists. The 2940 nm wavelength is used to deliver from 0 to 100 microns of ablation to the epidermis of the skin. This gives Halo the unique ability to provide separate treatments for the epidermis, which heals quickly, and dermis which remodels more slowly over time. The operator may choose one of three coverage-base treatment levels, and Halo calculates the exact amount of energy necessary to complete a safe and effective treatment. Intelligent energy delivery, combined with Dynamic Thermal Optimization, ensures precise and even treatments, each and every time. The benefits of a Halo treatment include both epidermal and deeper dermal pigmentation and tone and texture in the skin.

"Sciton's Halo is the first real innovation in lasers in the last decade," says Plastic Surgeon Jason Pozner, MD, FACS. "Hybrid Fractional Lasers are the next logical evolution in fractional resurfacing. With Halo, I can achieve results which I would have only expected from an ablative fractional laser, but get downtimes that I would normally see with a non-ablative fractional laser. It really is the best of both worlds."

Halo is available on the JOULE(TM) platform, which offers multiple modules to treat a wide range of indications. Visit www.HaloBySciton.com to learn more about Halo.

ABOUT SCITON: Sciton is committed to providing best-in-class laser and light solutions for medical professionals who want superior durability, performance and value. Sciton offers superior medical devices for laser-assisted lipolysis, fractional and full-coverage skin resurfacing, hair removal, phototherapy, wrinkle reduction, treatment of vascular and pigmented lesions, scar reduction, and acne. For more information, and a complete listing of Sciton systems, visit www.Sciton.com.

Lacee Naik
lacee.naik@sciton.com
650.493.9155

Share Like Tweet Add Email

Comments

comments powered by Disqus